United States - English - NLM (National Library of Medicine)

american regent, inc. - polysulfated glycosaminoglycan (unii: 268aw7000t) (polysulfated glycosaminoglycan - unii:268aw7000t) - polysulfated glycosaminoglycan 100 mg in 1 ml - adequan® i.m. multi-dose is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses. there are no known contraindications to the use of intramuscular polysulfated glycosaminoglycan.

United States - English - NLM (National Library of Medicine)

american regent, inc. - polysulfated glycosaminoglycan (unii: 268aw7000t) (polysulfated glycosaminoglycan - unii:268aw7000t) - adequan® i.m. is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses. there are no known contraindications to the use of intramuscular polysulfated glycosaminoglycan.

United States - English - NLM (National Library of Medicine)

american regent, inc. - polysulfated glycosaminoglycan (unii: 268aw7000t) (polysulfated glycosaminoglycan - unii:268aw7000t) - polysulfated glycosaminoglycan 250 mg in 1 ml - adequan is recommended for the treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal joint in horses. do not use in horses showing hypersensitivity to polysulfated glycosaminoglycan. do not administer adequan in the face of joint sepsis.

United States - English - NLM (National Library of Medicine)

american regent, inc. - polysulfated glycosaminoglycan (unii: 268aw7000t) (polysulfated glycosaminoglycan - unii:268aw7000t) - adequan® canine is recommended for intramuscular injection for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints. do not use in dogs showing hypersensitivity to psgag. psgag is a synthetic heparinoid; do not use in dogs with known or suspected bleeding disorders.

United States - English - NLM (National Library of Medicine)

elanco us inc. - polysulfated glycosaminoglycan (unii: 268aw7000t) (polysulfated glycosaminoglycan - unii:268aw7000t) - polysulfated glycosaminoglycan 100 mg in 1 ml

United States - English - NLM (National Library of Medicine)

nidaria technology ltd - octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm), homosalate (unii: v06sv4m95s) (homosalate - unii:v06sv4m95s), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox) - : ■ helps prevent sunburn ■ if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun. uses : ■ apply liberally 15 minutes before sun exposure ■ reapply: after 80 minutes of swimming or sweating, immediately after towel drying and at least every 2 hours ■ sun protection measures- spending time in the sun increases your risk of skin cancer and early skin aging. to decrease this risk, regularly use a sunscreen with a broad spectrum spf of 15 or higher and other sun protection measures including: ■ limit time in the sun, especially from 10 a.m.to 2 p.m.■ wear long-sleeve shirts, pants, hats, and sunglasses ■ children under 6 months: ask a doctor. directions

United States - English - NLM (National Library of Medicine)

nidaria technology ltd - octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm), homosalate (unii: v06sv4m95s) (homosalate - unii:v06sv4m95s), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox) - : ■ helps prevent sunburn ■ if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun. uses : ■ apply liberally 15 minutes before sun exposure ■ reapply: after 80 minutes of swimming or sweating, immediately after towel drying and at least every 2 hours ■ sun protection measures- spending time in the sun increases your risk of skin cancer and early skin aging. to decrease this risk, regularly use a sunscreen with a broad spectrum spf of 15 or higher and other sun protection measures including: ■ limit time in the sun, especially from 10 a.m.to 2 p.m.■ wear long-sleeve shirts, pants, hats, and sunglasses ■ children under 6 months: ask a doctor. directions

United States - English - NLM (National Library of Medicine)

nidaria technology ltd - octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm), homosalate (unii: v06sv4m95s) (homosalate - unii:v06sv4m95s), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox) - : ■ helps prevent sunburn ■ if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun. uses : ■ apply liberally 15 minutes before sun exposure ■ reapply: after 80 minutes of swimming or sweating, immediately after towel drying and at least every 2 hours ■ sun protection measures- spending time in the sun increases your risk of skin cancer and early skin aging. to decrease this risk, regularly use a sunscreen with a broad spectrum spf of 15 or higher and other sun protection measures including: ■ limit time in the sun, especially from 10 a.m.to 2 p.m.■ wear long-sleeve shirts, pants, hats, and sunglasses ■ children under 6 months: ask a doctor. directions

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - glycosaminoglycan polysulfate - parenteral liquid/solution/suspension - glycosaminoglycan polysulfate emulsifiers & surfactants active 100.0 mg/ml - musculoskeletal system - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - degenerative aseptic joint disease | traumatic degenerative joint d

United States - English - NLM (National Library of Medicine)

dechra veterinary products - pentosan polysulfate sodium (unii: 914032762y) (pentosan polysulfate - unii:f59p8b75r4) - horses with hypersensitivity to pentosan polysulfate sodium or any of the inactive ingredients in zycosan should not receive zycosan. do not use zycosan concurrently with other anticoagulant drugs. do not use in horses with clotting disorders or within 24 hours of surgical procedures (see warnings and precautions).